| 臺大學術典藏 |
2021-11-18T04:58:20Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-18T04:58:19Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-18T04:58:17Z |
Recent advances in the treatment of nasopharyngeal carcinoma
|
Chang J.T.-C; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:17Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
| 臺大學術典藏 |
2021-11-18T04:58:06Z |
Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas
|
Lin Y.-C; Chen K.-C; Lin C.-H; Kuo K.-T; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-18T04:58:05Z |
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation
|
Chen W.-Y; Kuo S.-H; Chen Y.-H; Lu S.-H; Tsai C.-L; Chia-Hsien Cheng J; Hong R.-L; Chen Y.-F; Hsu C.-J; Lin K.-N; JENG-YUH KO; Lou P.-J; Wang C.-P; Chong F.-C; Wang C.-W. |
| 臺大學術典藏 |
2021-11-18T04:58:04Z |
Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging
|
Wu L.-A; Liu H.-M; Wang C.-W; Chen Y.-F; Hong R.-L; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-18T04:58:03Z |
Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence
|
Chen J.L.-Y; Huang Y.-S; Kuo S.-H; Chen Y.-F; Hong R.-L; JENG-YUH KO; Lou P.-J; Tsai C.-L; Chen W.-Y; Wang C.-W. |
| 臺大學術典藏 |
2021-11-18T04:57:54Z |
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma
|
Chen J.L; Huang Y.-S; Kuo S.-H; Hong R.-L; JENG-YUH KO; Lou P.-J; Wang C.-W. |
| 臺大學術典藏 |
2021-11-18T04:57:53Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W; Hua K.-T; Li K.-C; Kao H.-F; Hong R.-L; JENG-YUH KO; Hsiao M; Kuo M.-L; Tan C.-T. |
| 臺大學術典藏 |
2021-11-18T04:57:51Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
| 臺大學術典藏 |
2021-11-15T07:48:45Z |
Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5 fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: A phase II study
|
Hong R.L; Sheen T.S; JENG-YUH KO; Hsu M.M; Wang C.C; Ting L.L. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
Factors affecting the overall survival after salvage surgery in patients with recurrent nasopharyngeal carcinoma at the primary site: Experience with 60 cases
|
Hsu M.-M; Hong R.-L; Ting L.-L; JENG-YUH KO; Sheen T.-S; Lou P.-J. |
| 臺大學術典藏 |
2021-11-15T07:48:43Z |
DNA content of nasopharyngeal carcinoma: An independent prognostic indicator
|
Hsu M.-M; Chiou C.-R; JENG-YUH KO; Sheen T.-S; Hong R.-L; Ting L.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:42Z |
Induction chemotherapy with mitomycin, epirubicin, cisplatin, fluorouracil, and leucovorin followed by radiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma
|
Hong R.-L; Ting L.-L; JENG-YUH KO; Hsu M.-M; Sheen T.-S; Lou P.-J; Wang C.-C; Chung N.-N; Lui L.T. |
| 臺大學術典藏 |
2021-11-15T07:48:41Z |
Comparison of Clinical and Molecular Surveillance in Patients with Advanced Nasopharyngeal Carcinoma after Primary Therapy: The Potential Role of Quantitative Analysis of Circulating Epstein-Barr Virus DNA
|
Hong R.-L; Lin C.-Y; Ting L.-L; JENG-YUH KO; Hsu M.-M. |
| 臺大學術典藏 |
2021-11-15T07:48:40Z |
Recent advances in the treatment of nasopharyngeal carcinoma
|
Chang J.T.-C; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:28Z |
Clinicopathological features of salivary and non-salivary adenoid cystic carcinomas
|
Lin Y.-C; Chen K.-C; Lin C.-H; Kuo K.-T; JENG-YUH KO; Hong R.-L. |
| 臺大學術典藏 |
2021-11-15T07:48:27Z |
Postoperative intensity-modulated radiotherapy for squamous cell carcinoma of the external auditory canal and middle ear: Treatment outcomes, marginal misses, and perspective on target delineation
|
Chen W.-Y; Kuo S.-H; Chen Y.-H; Lu S.-H; Tsai C.-L; Chia-Hsien Cheng J; Hong R.-L; Chen Y.-F; Hsu C.-J; Lin K.-N; JENG-YUH KO; Lou P.-J; Wang C.-P; Chong F.-C; Wang C.-W. |
| 臺大學術典藏 |
2021-11-15T07:48:26Z |
Osteoradionecrosis of the upper cervical spine after radiation therapy for head and neck cancer: Differentiation from recurrent or metastatic disease with MR imaging
|
Wu L.-A; Liu H.-M; Wang C.-W; Chen Y.-F; Hong R.-L; JENG-YUH KO |
| 臺大學術典藏 |
2021-11-15T07:48:25Z |
Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma: Treatment results and locoregional recurrence
|
Chen J.L.-Y; Huang Y.-S; Kuo S.-H; Chen Y.-F; Hong R.-L; JENG-YUH KO; Lou P.-J; Tsai C.-L; Chen W.-Y; Wang C.-W. |
| 臺大學術典藏 |
2021-11-15T07:48:15Z |
Intensity-modulated radiation therapy achieves better local control compared to three-dimensional conformal radiation therapy for T4-stage nasopharyngeal carcinoma
|
Chen J.L; Huang Y.-S; Kuo S.-H; Hong R.-L; JENG-YUH KO; Lou P.-J; Wang C.-W. |
| 臺大學術典藏 |
2021-11-15T07:48:14Z |
Histone methyltransferase G9a drives chemotherapy resistance by regulating the glutamate�Vcysteine ligase catalytic subunit in head and neck squamous cell carcinoma
|
Liu C.-W; Hua K.-T; Li K.-C; Kao H.-F; Hong R.-L; JENG-YUH KO; Hsiao M; Kuo M.-L; Tan C.-T. |
| 臺大學術典藏 |
2021-11-15T07:48:12Z |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study
|
Hong R.L; Hsiao C.F; Ting L.L; JENG-YUH KO; Wang C.W; Chang J.T.C; Lou P.J; Wang H.M; Tsai M.H; Lai S.C; Liu T.W. |
